| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.23 | 3e-06 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.0006 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.0008 |